ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIOG Biotech Growth Trust (the) Plc

971.00
17.00 (1.78%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  17.00 1.78% 971.00 967.00 974.00 983.00 950.00 956.00 60,022 16:35:20
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt -32.42M -41.3M -1.0034 -9.70 400.47M

The Biotech Growth Trust Plc - Issue of Equity

30/07/2020 5:37pm

PR Newswire (US)


Biotech Growth (LSE:BIOG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Biotech Growth Charts.

THE BIOTECH GROWTH TRUST PLC

30 July 2020

Allotment of Ordinary Shares

THE BIOTECH GROWTH TRUST PLC (the “Company”) announces the allotment of 55,000 Ordinary shares of 25p each fully paid from its block listing authority. 

These shares were issued today at a price of 1244.00 pence per Ordinary share, which equates to a premium to the estimated  cum income net asset value per Ordinary share at the time of transaction of 1.4%  The cum income net asset value per Ordinary share at the close of business on 29 July 2020 was 1241.39 pence.

Following this issue, the Company has the ability to issue a further 5,813,134 Ordinary shares its block listing facility.

Following this transaction the Company hereby notifies the market that it has in issue 39,452,269 Ordinary shares of 25p each all with voting rights.  No shares were held in treasury at the date of announcement.

The figure of 39,452,269 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Enquiries:

Mark Pope                 

Frostrow Capital LLP            

Tel: 020 3 008 4913

Copyright y 30 PR Newswire

1 Year Biotech Growth Chart

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

1 Month Biotech Growth Chart

Your Recent History

Delayed Upgrade Clock